Jul 16, 2025, 01:00 AM by User Not Found

Bio-IT World | In recent years, phosphorylated tau has garnered so much attention as one of the “bad guys” of Alzheimer’s disease that the scientific community may have developed a bit of tunnel vision. A medical doctor in Sweden seeks to remedy the situation as a “champion” of the biomarker based on the critical if forgotten physiological role it plays in the healthy human brain.

Jul 15, 2025, 09:16 AM by

Jul 15, 2025, 09:16 AM by

New publication addresses IV therapy silent threat, identifies ivWatch as ‘transformative tool’ in NICU patient care

Jul 15, 2025, 01:00 AM by User Not Found

Bio-IT World | Massive progress has been enabled by individual applications of artificial intelligence (AI) and machine learning (ML) in drug discovery, AlphaFold being one of the most prominent, due to their ability to predict the type of molecules that should have a positive impact on patient care.

Jul 10, 2025, 10:15 AM by

VieCure announced a strategic partnership with Guardant Health to embed Guardant’s next-generation sequencing-based precision oncology tests into the VieCure Halo Intelligence platform.

Jul 10, 2025, 10:15 AM by

PubHive wins GHP's 2025 award for Most Innovative Literature Review Software, redefining life science workflows with AI-powered automation.

Jul 10, 2025, 10:15 AM by

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced dosing of the first patient in the 48 mg, multiple ascending dose (MAD) cohort of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR), for the treatment of obesity. Top-line data is expected in the fourth quarter of 2025.

Jul 10, 2025, 10:15 AM by

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received UK Conformity Assessed marking for its Avantect® Pancreatic Cancer Test. The UKCA mark, established as part of the United Kingdom’s independent product safety regulatory framework following its departure from the European Union, signifies compliance with UK medical device regulations and paves the way for commercial availability in the UK market.

Jul 10, 2025, 01:00 AM by User Not Found

Bio-IT World | David Hewlett, renowned for portraying Dr. Rodney McKay in the Stargate franchise, recently joined Trends from the Trenches podcast to discuss the fascinating intersection of Hollywood, science communication, and lifelong learning. Hewlett and host Ari Berman explore how entertainment can serve as a powerful gateway to scientific curiosity and innovation.

Jul 9, 2025, 09:14 AM by

Bio-Rad Laboratories today announced the launch of four new Droplet Digital™ PCR (ddPCR™) platforms. The newly introduced instruments include Bio-Rad’s QX Continuum™ ddPCR system along with the QX700™ series of ddPCR platforms acquired as part of the company’s recently completed acquisition of digital PCR developer Stilla Technologies.

Jul 9, 2025, 09:14 AM by

July 8 2025 – Cambridge UK – Cresset, a leading provider of innovative solutions for the digitization of drug discovery, announces the acquisition of Molab.ai, a pioneer in artificial intelligence technologies tailored for molecular research. This strategic acquisition will combine Cresset’s powerful computational chemistry platform with Molab.ai’s proven capability to build highly predictive ADME models. It marks a significant step in Cresset’s mission to empower scientists with cutting-edge tools to accelerate drug discovery.

Jul 9, 2025, 09:14 AM by

Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology

Jul 9, 2025, 09:14 AM by

SPT Labtech today announced a strategic collaboration with Semarion. The partnership will integrate SPT Labtech’s firefly® liquid handling platform with Semarion’s SemaCyte® microcarrier technology to develop a flexible, scalable, and automated workflow that simplifies and accelerates key stages of adherent cell assay development.

Jul 9, 2025, 01:00 AM by User Not Found

Bio-IT World | Consumer genomics pioneer 23andMe will be returning to its co-founder and former CEO as Anne Wojcicki’s TTAM Research Institute outbids Regeneron to buy 23andMe out of bankruptcy—as long as no more state attorneys general object. The current iteration of the sale is expected to close on July 8.

Jul 8, 2025, 01:00 AM by User Not Found

Bio-IT World | Pangaea Data has entered into a collaboration agreement with Alexion to develop an Artificial Intelligence Clinical Decision Support System; Dell Technologies will develop NERSC-10, the next flagship supercomputer at the National Energy Research Scientific Computing Center; and more.

Jul 7, 2025, 08:29 AM by

Jul 7, 2025, 08:29 AM by

CD Bioparticles announces quality Purified Exosomes to support research in drug delivery.

Jul 7, 2025, 08:29 AM by

Jul 3, 2025, 08:19 AM by

PHARMASEAL, provider of the Engility® Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF), has announced a Technology Integration Partnership with Viedoc, a global leader in Electronic Data Capture (EDC) and eClinical technologies. This collaboration integrates PHARMASEAL’s advanced CTMS platform with Viedoc’s cutting-edge EDC capabilities, including its flagship product Viedoc Clinic, to deliver a more integrated solution for life science companies managing clinical trials worldwide.

Jul 3, 2025, 08:19 AM by

The research will focus on developing faster and more accurate methods for predicting drug metabolism